Acta Scientific Microbiology

Editorial Volume 7 Issue 2

Sarcoidosis in Association with COVID-19

Attapon Cheepsattayakorn1-4*, Ruangrong Cheepsattayakorn5 and Porntep Siriwanarangsun1

1Faculty of Medicine, Western University, Pathumtani Province, Thailand
2Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
310th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
4Department of Disease Control, Ministry of Public Health, Thailand
5Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Thailand.

Received: December 22, 2023; Published: January 01, 2024

Abstract

Several post-COVID-19 inflammatory disorders and autoimmune diseases have been discovered [1] since global COVID-19 pandemic started [2]. Association between these diseases is still to be investigated [2]. Common genes between COVID-19 and sarcoidosis are demonstrated in Figure 1, 2 [3]. Nevertheless, sarcoidosis organ involvement, demographics, and type of sarcoidosis treatment at the time of COVID-19 diagnosis are related to hospital admission, non-invasive ventilation or high flow oxygenation, intubation

References

  1. Galeotti C and Baryl J. “Autoimmune and inflammatory diseases following COVID-19”. Nature Reviews Rheumatology 8 (2020): 413-414.
  2. Racil H., et al. “Can coronavirus disease 2019 induce sarcoidosis : a case report”. Thoracic Research and Practice 1 (2023): 45-48.
  3. Mogal R., et al. “Common genetic aspects between COVID-19 and sarcoidosis : a network-based approach using expression data”. Biochemistry and Biophysics Reports 29 (2022): 101219.
  4. Nadeem O., et al. “Outcome in patients with sarcoidosis diagnosed with COVID-19”. Presentation at Chest 2021 annual meeting (2021): 17-20.
  5. Dureault A., et al. “Severe infections in sarcoidosis : incidence, predictors and long-term outcome in a cohort of 585 patients”. Medicine (Baltimore) 96 (2017): e8846.
  6. Bernardinello N., et al. “Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis”. Diagnostics (Basel)9 (2021): 1558.
  7. Dhomps A., et al. “Isolated muscular sarcoidosis revealed by hypercalcemia”. Clinical Nuclear Medicine 10 (2019): 824-825.
  8. Ashjan K., et al. “18F-FDG PET/MRI for diagnosis and treatment efficacy evaluation of spinal sarcoidosis”. Clinical Nuclear Medicine1 (2024): e28-e30.
  9. Alan S and Dagmar HS. “FDG PET of Isolated Right Ventricular Sarcoidosis”. Clinical Nuclear Medicine2 (2023): 184-185.

Citation

Citation: Attapon Cheepsattayakorn., et al. “Sarcoidosis in Association with COVID-19".Acta Scientific Microbiology 7.2 (2024): 01-02.

Copyright

Copyright: © 2024 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US